David Francis Carroll, SVP, Chief Financial Officer at IVERIC bio, Inc. (ISEE), sold 63,500 shares at $37.04 ($2.4M) on 2023-05-01, disclosed to the SEC on 2023-05-03.
Scheduled sale ($2.4M) by SVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ISEE | SELL | 2022-12-20 | $244K | — | Filing → |
| ISEE | SELL | 2022-12-13 | $297K | — | Filing → |
| ISEE | SELL | 2022-04-05 | $1.7M | — | Filing → |